Contact
searchSearch
HMP Global

Dermatology Topic Center

interview


Edwards
Interview
Q&A – Incyte Ingenuity Awards in Vitiligo
10/26/2023
Todd Edwards, Group Vice President & Head of the Dermatology Business Unit at Incyte, delves into the topic of vitiligo. Drawing from his extensive 20+ years of experience in the pharmaceutical industry, which includes prominent leadership...
Todd Edwards, Group Vice President & Head of the Dermatology Business Unit at Incyte, delves into the topic of vitiligo. Drawing from his extensive 20+ years of experience in the pharmaceutical industry, which includes prominent leadership...
Todd Edwards, Group Vice...
10/26/2023
First Report Managed Care
Headshot of Gary Owens
Interview
An Overview of Vitiligo: Prevalence, Comorbidities, and Available Therapies
05/30/2023
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of...
05/30/2023
First Report Managed Care
Headshot of Nikolaos Sideris, Aristotle University, Thessaloniki, Greece
Interview
The Future of Atopic Dermatitis: Comparative Studies, Biomarker Testing
11/01/2022
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD...
11/01/2022
First Report Managed Care
Headshot of Amy S Paller, MD, Northwestern University Feinberg School of Medicine
Interview
Topicals for Atopic Dermatitis: Optimizing Treatment Before Systemic Therapy
08/30/2022
Amy S Paller, MD, chair, department of dermatology, Northwestern University, Feinberg School of Medicine, reviews available and incoming treatments for atopic dermatitis, as well as strategies to optimize the use of topicals before pursuing...
Amy S Paller, MD, chair, department of dermatology, Northwestern University, Feinberg School of Medicine, reviews available and incoming treatments for atopic dermatitis, as well as strategies to optimize the use of topicals before pursuing...
Amy S Paller, MD, chair,...
08/30/2022
First Report Managed Care
Headshot of Lawrence Green, MD
Interview
Treatment Considerations for Pediatric vs Adult Patients With Atopic Dermatitis
07/29/2022
Lawrence J Green, MD, clinical professor of dermatology, George Washington University School of Medicine, reviews how clinicians approach treatment options for atopic dermatitis, as well as where the future of care my be headed as more agents...
Lawrence J Green, MD, clinical professor of dermatology, George Washington University School of Medicine, reviews how clinicians approach treatment options for atopic dermatitis, as well as where the future of care my be headed as more agents...
Lawrence J Green, MD, clinical...
07/29/2022
First Report Managed Care
Headshot of Katherine A Kelly, Wake Forest University
Interview
Research Demonstrates Efficacy, Safety of Tralokinumab for Atopic Dermatitis
07/15/2022
Katherine A Kelly, Center for Dermatology Research, department of dermatology, Wake Forest School of Medicine, discusses findings showing the potential of tralokinumab to reduce symptom burden and boost quality of life in patients with atopic...
Katherine A Kelly, Center for Dermatology Research, department of dermatology, Wake Forest School of Medicine, discusses findings showing the potential of tralokinumab to reduce symptom burden and boost quality of life in patients with atopic...
Katherine A Kelly, Center for...
07/15/2022
First Report Managed Care
Headshot of Ed Pezalla, Enlightenment Bioconsult
Interview
Impact of New Atopic Dermatitis Treatments on Formulary Decision Making
05/27/2022
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, reviews what payers should keep in mind regarding outcome measures and treatment guidelines as new therapies for atopic dermatitis continue hitting the market.
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, reviews what payers should keep in mind regarding outcome measures and treatment guidelines as new therapies for atopic dermatitis continue hitting the market.
Ed Pezalla, MD, MPH, chief...
05/27/2022
First Report Managed Care
Headshot of Dr Raj Chovatiya, assistant professor of dermatology, director of the Center for Eczema and Itch at the Northwestern University Feinberg School of Medicine
Interview
JAK Inhibitors, Monoclonal Antibodies, Corticosteroids: Choosing a Treatment for Atopic Dermatitis
05/25/2022
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, breaks down treatment options for atopic dermatitis and why clinicians may opt for one class of agents over another.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, breaks down treatment options for atopic dermatitis and why clinicians may opt for one class of agents over another.
Raj Chovatiya, MD, PhD,...
05/25/2022
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Conference Coverage
The Impact of Fatigue on Prospective Memory in Persons With MS
05/23/2024
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons...
05/23/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care
Poll
Opinions on RSV Mutations
07/29/2024
Are you concerned about the impact of RSV mutations on the effectiveness of current therapeutics in preventing the virus from spreading?
Are you concerned about the impact of RSV mutations on the effectiveness of current therapeutics in preventing the virus from spreading?
Are you concerned about the...
07/29/2024
First Report Managed Care
News
Study Finds Gemcitabine-Docetaxel Combo Outperforms BCG in Treating High-Risk Bladder Cancer
08/23/2024
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel...
08/23/2024
First Report Managed Care
Conference Coverage
How AI is Revolutionizing Rare Disease Diagnosis and Treatment Despite Lack of Diversity in Patient Populations
09/23/2024
AI has the potential to revolutionize the diagnosis and treatment of rare diseases, but challenges in patient diversity are being addressed through cross-border collaboration and engagement with patient communities.
AI has the potential to revolutionize the diagnosis and treatment of rare diseases, but challenges in patient diversity are being addressed through cross-border collaboration and engagement with patient communities.
AI has the potential to...
09/23/2024
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use